| Tipo : |
periódico |
| Enlace : |
https://pubmed.ncbi.nlm.nih.gov/18032138/ |
|
| Los equipos de investigación : |
Nutley - Roche Laboratories |
| Autores : |
Winiarski AP, Infeld MH, Tscherne R, Bachinsky M, Rucki R, Nagano-Mate K. |
| Título : |
Preparation and stability of extemporaneous oral liquid formulations of oseltamivir using commercially available capsules. |
| número : |
J Am Pharm Assoc ; 47, 6; 747-755. 2007 |
|
| Nivel de evidencia : |
|
| La estabilidad física : |
|
| Estabilidad química : |
|
| otros métodos : |
|
| Comentarios : |
|
Lista de la molécula
 Oseltamivir
|
 |
 |
 |
 |
450 mg
Tamiflu® |
| Jarabe de cereza |
>> 30 ml |
|
23-27°C |
 |
| 5 |
 |
|
|
|
|
|
450 mg
Tamiflu® |
|
28-32°C |
|
| 13 |
|
|
|
|
|
|
450 mg
Tamiflu® |
| Jarabe de cereza |
>> 30 ml |
|
3-7°C |
|
| 35 |
|
|
|
|
|
|
450 mg
Tamiflu® |
|
3-7°C |
|
| 35 |
|
|
|
|
 |
|
450 mg
Tamiflu® |
| Jarabe de cereza |
>> 30 ml |
|
23-27°C |
|
| 5 |
|
|
|
|
|
|
450 mg
Tamiflu® |
|
28-32°C |
|
| 13 |
|
|
|
|
|
|
450 mg
Tamiflu® |
| Jarabe de cereza |
>> 30 ml |
|
3-7°C |
|
| 35 |
|
|
|
|
|
|
450 mg
Tamiflu® |
|
3-7°C |
|
| 35 |
|
|
|
|
|
